A detailed history of Highline Wealth Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Highline Wealth Partners LLC holds 630 shares of ABT stock, worth $81,918. This represents 0.02% of its overall portfolio holdings.

Number of Shares
630
Previous 572 10.14%
Holding current value
$81,918
Previous $76.7 Million 3.02%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

BUY
$123.62 - $134.59 $7,169 - $7,806
58 Added 10.14%
630 $79 Million
Q3 2025

Oct 14, 2025

SELL
$120.51 - $136.62 $241 - $273
-2 Reduced 0.35%
572 $76.7 Million
Q2 2025

Jul 16, 2025

BUY
$123.95 - $138.08 $13,510 - $15,050
109 Added 23.44%
574 $78.1 Million
Q1 2025

Apr 17, 2025

BUY
$111.1 - $140.22 $7,777 - $9,815
70 Added 17.72%
465 $61.7 Million
Q4 2024

Jan 10, 2025

BUY
$111.93 - $119.39 $7,835 - $8,357
70 Added 21.54%
395 $44.7 Million
Q3 2024

Oct 25, 2024

BUY
$100.07 - $118.13 $32,522 - $38,392
325 New
325 $37.1 Million
Q2 2024

Oct 28, 2024

SELL
$100.73 - $112.44 $8,763 - $9,782
-87 Reduced 26.77%
238 $24.7 Million
Q1 2024

Oct 28, 2024

SELL
$109.52 - $120.96 $11,061 - $12,216
-101 Reduced 31.08%
224 $25.4 Million
Q4 2023

Oct 28, 2024

SELL
$90.19 - $110.4 $5,952 - $7,286
-66 Reduced 22.84%
223 $24.5 Million
Q3 2023

Oct 28, 2024

BUY
$95.53 - $114.62 $6,304 - $7,564
66 Added 29.6%
289 $28 Million
Q2 2023

Oct 29, 2024

SELL
$100.78 - $112.29 $10,279 - $11,453
-102 Reduced 31.38%
223 $24.3 Million
Q1 2023

Oct 28, 2024

SELL
$96.86 - $114.01 $9,879 - $11,629
-102 Reduced 31.38%
223 $22.6 Million
Q4 2022

Oct 29, 2024

SELL
$95.06 - $111.52 $9,696 - $11,375
-102 Reduced 31.38%
223 $24.5 Million
Q3 2022

Oct 29, 2024

SELL
$96.76 - $112.03 $9,869 - $11,427
-102 Reduced 31.38%
223 $21.6 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Highline Wealth Partners LLC Portfolio

Follow Highline Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highline Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highline Wealth Partners LLC with notifications on news.